Literature DB >> 10397423

Dialogical engagement with voices: a single case study.

P Davies1, P Thomas, I Leudar.   

Abstract

This paper raises the possibility that a dialogical, or discursive, model of human experience may be useful in helping someone who experiences verbal hallucinations. The model regards verbal hallucinations as a variety of inner speech with dialogical properties. The explication of these properties in the context of a personal narrative allowed the individual to engage in dialogue with the voices, through the medium of a new, supportive and positive voice. This process made it possible to introduce moral responses to distressing and potentially dangerous imperative verbal hallucinations, through the mediation of the new voice. Her dialogical engagement with this voice enabled her to deal effectively with troublesome voices, and was a powerful source of self-esteem. We briefly present the theoretical perspective underlying this approach, and compare and contrast the approach with cognitive-behavioural techniques.

Entities:  

Mesh:

Year:  1999        PMID: 10397423     DOI: 10.1348/000711299159934

Source DB:  PubMed          Journal:  Br J Med Psychol        ISSN: 0007-1129


  3 in total

Review 1.  Do we need multiple models of auditory verbal hallucinations? Examining the phenomenological fit of cognitive and neurological models.

Authors:  Simon R Jones
Journal:  Schizophr Bull       Date:  2008-09-26       Impact factor: 9.306

2.  The tangled roots of inner speech, voices and delusions.

Authors:  Cherise Rosen; Simon McCarthy-Jones; Kayla A Chase; Clara S Humpston; Jennifer K Melbourne; Leah Kling; Rajiv P Sharma
Journal:  Psychiatry Res       Date:  2018-04-09       Impact factor: 3.222

3.  Sensory and Quasi-Sensory Experiences of the Deceased in Bereavement: An Interdisciplinary and Integrative Review.

Authors:  Karina Stengaard Kamp; Edith Maria Steffen; Ben Alderson-Day; Paul Allen; Anne Austad; Jacqueline Hayes; Frank Larøi; Matthew Ratcliffe; Pablo Sabucedo
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.